Bioventus Inc.·4

Apr 5, 4:38 PM ET

Pavesio Alessandra 4

4 · Bioventus Inc. · Filed Apr 5, 2021

Insider Transaction Report

Form 4
Period: 2021-02-11
Pavesio Alessandra
SVP & Chief Science Officer
Transactions
  • Award

    Restricted Stock Units

    2021-04-01+61,47661,476 total
    Class A Common Stock (61,476 underlying)
  • Award

    Stock Options

    2021-04-01+4,9004,900 total
    Exercise: $15.23Exp: 2031-03-31Class A Common Stock (4,900 underlying)
  • Purchase

    Common Stock

    2021-02-11$13.00/sh+1,000$13,0001,000 total
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
  • [F2]The restricted stock units vest on April 1, 2022 and have no expiration date.
  • [F3]The stock option vests in four equal annual installments beginning on April 1, 2022.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION